Double-Dose Firmonertinib Boosts EGFR L858R Lung Cancer Treatment
A groundbreaking advancement in the fight against non-small-cell lung cancer (NSCLC) has emerged from a recent multicenter phase II study ...
A groundbreaking advancement in the fight against non-small-cell lung cancer (NSCLC) has emerged from a recent multicenter phase II study ...
In a groundbreaking advancement for the management of breast cancer patients afflicted with brain metastases, researchers have developed a novel ...
In a groundbreaking retrospective study published in BMC Cancer, researchers have unveiled the significant prognostic potential of peripheral lymphocyte count ...
A groundbreaking study conducted by researchers at the Seville Biomedical Institute (IBiS) has unveiled a novel molecular mechanism that underpins ...
In a landmark advancement for the treatment of limited-stage small cell lung cancer (LS-SCLC), researchers at the National Cancer Center ...
Cancer remains a formidable adversary in global health, affecting millions annually and presenting persistent challenges to effective treatment. Despite significant ...
In the rapidly evolving world of cancer research, understanding the tumor immune microenvironment has become paramount to developing effective immunotherapy ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine